The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain
出版年份 2017 全文链接
标题
The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-06-30
DOI
10.1038/s41598-017-05029-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622
- (2016) Anne F. Schott et al. BREAST CANCER RESEARCH AND TREATMENT
- TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis
- (2016) Z. Mitri et al. CLINICAL CANCER RESEARCH
- Bone pain: current and future treatments
- (2016) Charlotte Ørsted Frost et al. CURRENT OPINION IN PHARMACOLOGY
- Effects of Src-kinase inhibition in cancer-induced bone pain
- (2016) Milena De Felice et al. Molecular Pain
- Randall Selitto pressure algometry for assessment of bone-related pain in rats
- (2015) S. Falk et al. EUROPEAN JOURNAL OF PAIN
- Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability
- (2015) A.A. Stepanenko et al. GENE
- Kinesin superfamily protein 17 contributes to the development of bone cancer pain by participating in NR2B transport in the spinal cord of mice
- (2015) MING LIU et al. ONCOLOGY REPORTS
- Pain and Nociception: Mechanisms of Cancer-Induced Bone Pain
- (2014) Sarah Falk et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of c-Kit signaling is associated with reduced heat and cold pain sensitivity in humans
- (2014) Marta Ceko et al. PAIN
- Src Family Kinase Inhibition as a Novel Strategy to Augment Melphalan-Based Regional Chemotherapy of Advanced Extremity Melanoma
- (2013) Yoshihiro Tokuhisa et al. ANNALS OF SURGICAL ONCOLOGY
- Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells
- (2013) Alex Y Chang et al. BMC CANCER
- Antitumor effects of Dasatinib on laryngeal squamous cell carcinoma in vivo and in vitro
- (2013) Yan Song et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Inhibition of protein tyrosine phosphatases in spinal dorsal horn attenuated inflammatory pain by repressing Src signaling
- (2013) Zhan-Wei Suo et al. NEUROPHARMACOLOGY
- Inhibition of breast cancer-cell glutamate release with sulfasalazine limits cancer-induced bone pain
- (2013) Robert G. Ungard et al. PAIN
- Pain outcomes in patients with advanced breast cancer and bone metastases
- (2012) Charles S. Cleeland et al. CANCER
- Targeted Inhibition of Src Kinase with Dasatinib Blocks Thyroid Cancer Growth and Metastasis
- (2012) C. M. Chan et al. CLINICAL CANCER RESEARCH
- Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice
- (2012) Rikke Rie Hansen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Arcuate Src activation-induced phosphorylation of NR2B NMDA subunit contributes to inflammatory pain in rats
- (2012) Longsheng Xu et al. JOURNAL OF NEUROPHYSIOLOGY
- Intrathecal Injection of Spironolactone Attenuates Radicular Pain by Inhibition of Spinal Microglia Activation in a Rat Model
- (2012) Yu-e Sun et al. PLoS One
- Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects
- (2012) Antonio Garcia-Gomez et al. PLoS One
- Blocking EphB1 Receptor Forward Signaling in Spinal Cord Relieves Bone Cancer Pain and Rescues Analgesic Effect of Morphine Treatment in Rodents
- (2011) S. Liu et al. CANCER RESEARCH
- Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors
- (2011) Shunji Takahashi et al. CANCER SCIENCE
- Mechanisms of Cancer-induced Bone Pain
- (2011) T. Middlemiss et al. CLINICAL ONCOLOGY
- Update on the Systematic Review of Palliative Radiotherapy Trials for Bone Metastases
- (2011) E. Chow et al. CLINICAL ONCOLOGY
- Dasatinib: An Anti-Tumour Agent via Src Inhibition
- (2011) Antonio Gnoni et al. CURRENT DRUG TARGETS
- Inhibition of p38-MAPK Signaling Pathway Attenuates Breast Cancer Induced Bone Pain and Disease Progression in a Murine Model of Cancer-Induced Bone Pain
- (2011) Devki Sukhtankar et al. Molecular Pain
- Microarchitectural adaptations in aging and osteoarthrotic subchondral bone issues
- (2010) Ming Ding Acta Orthopaedica
- Bone cancer pain
- (2010) Juan Miguel Jimenez-Andrade et al. Annals of the New York Academy of Sciences
- The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
- (2010) Hichame Id Boufker et al. BMC CANCER
- The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo
- (2010) Kate Vandyke et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts
- (2010) Y-C Lee et al. ONCOGENE
- Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis
- (2009) T Koreckij et al. BRITISH JOURNAL OF CANCER
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
- (2009) Xiang H.-F. Zhang et al. CANCER CELL
- MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell lines
- (2009) Jonathan T. Sims et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Inhibition of Src Phosphorylation Alters Metastatic Potential of Osteosarcoma In vitro but not In vivo
- (2009) P. Hingorani et al. CLINICAL CANCER RESEARCH
- Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
- (2009) G. D. Demetri et al. CLINICAL CANCER RESEARCH
- The role of N-methyl-d-aspartate receptor subunit NR2B in spinal cord in cancer pain
- (2009) XiaoPing Gu et al. EUROPEAN JOURNAL OF PAIN
- Disruption of Fibroblast Growth Factor Receptor Signaling in Nonmyelinating Schwann Cells Causes Sensory Axonal Neuropathy and Impairment of Thermal Pain Sensitivity
- (2009) M. Furusho et al. JOURNAL OF NEUROSCIENCE
- The Role of Src in Solid Tumors
- (2009) D. L. Wheeler et al. ONCOLOGIST
- The c-kit signaling pathway is involved in the development of persistent pain
- (2009) Yan-Gang Sun et al. PAIN
- Differential activation of spinal cord glial cells in murine models of neuropathic and cancer pain
- (2008) Andreas Hald et al. EUROPEAN JOURNAL OF PAIN
- Targeting Src signaling in metastatic bone disease
- (2008) John Araujo et al. INTERNATIONAL JOURNAL OF CANCER
- Therapeutic concentrations of dasatinib inhibit in vitro osteoclastogenesis
- (2008) K Vandyke et al. LEUKEMIA
- Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex
- (2008) Xue Jun Liu et al. NATURE MEDICINE
- EphrinB2 induces tyrosine phosphorylation of NR2B via Src-family kinases during inflammatory hyperalgesia
- (2008) S. Slack et al. NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started